UB Paderborn / Katalog / Suche / in CDI

Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS3-05-GS3-05

2022

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

The Lancet (British edition), 2022-04, Vol.399 (10336), p.1695-1707

2022

Link zum Volltext

Verfügbarkeit prüfen

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

The lancet oncology, 2022-11, Vol.23 (11), p.1367-1377

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting

Clinical cancer research, 2001-06, Vol.7 (6), p.1577-1581

2001

Link zum Volltext

Verfügbarkeit prüfen

Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.471-471

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-18-16: First line aromatase inhibitor (AI) + palbociclib with randomized switch to fulvestrant + palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Global safety results of PADA-1, a UCBG-GINECO phase III trial

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-18-16

2022

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.19-19

2022

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)

European journal of cancer (1990), 2020-09, Vol.136, p.25-34

2020

Link zum Volltext

Verfügbarkeit prüfen

Impacts of microplastics and the associated plastisphere on physiological, biochemical, genetic expression and gut microbiota of the filter-feeder amphioxus

Environment international, 2023-02, Vol.172, p.107750, Article 107750

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of limb-specific Lmx1b auto-regulatory modules with Nail-patella syndrome pathogenicity

Nature communications, 2021-09, Vol.12 (1), p.5533-5533, Article 5533

2021

Link zum Volltext

Verfügbarkeit prüfen

CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment

PloS one, 2016-02, Vol.11 (2), p.e0149184-e0149184

2016

Link zum Volltext

Verfügbarkeit prüfen

Responses to iron oxide and zinc oxide nanoparticles in echinoderm embryos and microalgae: uptake, growth, morphology, and transcriptomic analysis

Nanotoxicology, 2020-12, Vol.14 (10), p.1342-1361

2020

Link zum Volltext

Verfügbarkeit prüfen

Vegetable oil-based hybrid microparticles as a green and biocompatible system for subcutaneous drug delivery

International journal of pharmaceutics, 2021-01, Vol.592, p.120070-120070, Article 120070

2021

Link zum Volltext

Verfügbarkeit prüfen

Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity

European journal of human genetics : EJHG, 2016-01, Vol.24 (1), p.44-50

2016

Link zum Volltext

Verfügbarkeit prüfen

Locoregional failure after postoperative flank irradiation for nephroblastoma: Results from the French cohort of the SIOP‐2001 trial

Pediatric blood & cancer, 2022-12, Vol.69 (12), p.e29950-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay

Frontiers in oncology, 2020-05, Vol.10, p.712-712

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors

Gynecologic oncology, 2017-03, Vol.144 (3), p.541-546

2017

Link zum Volltext

Verfügbarkeit prüfen

Boosting syntax training with temporally regular musical primes in children with cochlear implants

Annals of physical and rehabilitation medicine, 2018-11, Vol.61 (6), p.365-371

2018

Link zum Volltext

Verfügbarkeit prüfen

Respective Roles of Surgery, Chemotherapy, and Radiation Therapy for Recurrent Pediatric and Adolescent Ependymoma: A National Multicentric Study

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.404-415

2023

Link zum Volltext

Verfügbarkeit prüfen

Rapid and Accurate Identification of Human Isolates of Pasteurella and Related Species by Sequencing the sodA Gene

Journal of Clinical Microbiology, 2005-05, Vol.43 (5), p.2307-2314

2005

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial

Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting

Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC)

Abstract P1-18-16: First line aromatase inhibitor (AI) + palbociclib with randomized switch to fulvestrant + palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Global safety results of PADA-1, a UCBG-GINECO phase III trial

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial

Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

Impacts of microplastics and the associated plastisphere on physiological, biochemical, genetic expression and gut microbiota of the filter-feeder amphioxus

Identification of limb-specific Lmx1b auto-regulatory modules with Nail-patella syndrome pathogenicity

CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment

Responses to iron oxide and zinc oxide nanoparticles in echinoderm embryos and microalgae: uptake, growth, morphology, and transcriptomic analysis

Vegetable oil-based hybrid microparticles as a green and biocompatible system for subcutaneous drug delivery

Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity

Comprehensive In Vivo Interrogation Reveals Phenotypic Impact of Human Enhancer Variants

Locoregional failure after postoperative flank irradiation for nephroblastoma: Results from the French cohort of the SIOP‐2001 trial

Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay

Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors

Boosting syntax training with temporally regular musical primes in children with cochlear implants

Respective Roles of Surgery, Chemotherapy, and Radiation Therapy for Recurrent Pediatric and Adolescent Ependymoma: A National Multicentric Study

Duplication of 10q24 locus: broadening the clinical and radiological spectrum

Rapid and Accurate Identification of Human Isolates of Pasteurella and Related Species by Sequencing the sodA Gene

Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model

Multiplex targeted high‐throughput sequencing in a series of 352 patients with congenital limb malformations

Suchergebnisse filtern